Scancell Investors
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.
Headquarters:
Nottingham, Nottingham, United Kingdom
Founded Date:
1996
Investor Type:
Healthcare Company
Number Of Exists:
N/A
Technology:
Advanced Longevity (R&D)
Employee Number:
11-50
Industry:
Advanced and Next Generation Therapies (Various)